000			02054 a2200589 4500
005			20250514165136.0
264		0	_c20040324
008			200403s 0 0 eng d
022			_a0887-6924
024	7		_a10.1038/sj.leu.2403253 _2doi
040			_aNLM _beng _cNLM
100	1		_aRamakers-van Woerden, N L
245	0	0	_aIn vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. _h[electronic resource]
260			_bLeukemia _cMar 2004
300			_a521-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism
650	0	4	_aAge Distribution
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aFemale
650	0	4	_aGene Rearrangement
650	0	4	_aHistone-Lysine N-Methyltransferase
650	0	4	_aHumans
650	0	4	_aImmunophenotyping
650	0	4	_aIn Vitro Techniques
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aMale
650	0	4	_aMyeloid-Lymphoid Leukemia Protein
650	0	4	_aNeoplasm Proteins _xmetabolism
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aProto-Oncogenes
650	0	4	_aTranscription Factors
650	0	4	_aVault Ribonucleoprotein Particles _xmetabolism
700	1		_aBeverloo, H B
700	1		_aVeerman, A J P
700	1		_aCamitta, B M
700	1		_aLoonen, A H
700	1		_avan Wering, E R
700	1		_aSlater, R M
700	1		_aHarbott, J
700	1		_aden Boer, M L
700	1		_aLudwig, W D
700	1		_aHaas, O A
700	1		_aJanka-Schaub, G E
700	1		_aPieters, R
773	0		_tLeukemia _gvol. 18 _gno. 3 _gp. 521-9
856	4	0	_uhttps://doi.org/10.1038/sj.leu.2403253 _zAvailable from publisher's website
999			_c14441085 _d14441085